Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Inovio Pharmaceuticals Primed For a Comeback?

TheMotleyFool

0 0

Is Inovio Pharmaceuticals Primed For a Comeback?Photo, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

It seems like a long time ago that Inovio Pharmaceuticals (NASDAQ: INO) was considered a leader in the race to develop an effective coronavirus vaccine. The biotech was soundly defeated in that competition, and while it is trying to play catch up, other players have already racked up billions in sales from their vaccines.

Unsurprisingly, investors mostly gave up on Inovio, and its shares have lost more than half their value in the past 12 months. But some recent developments could help Inovio stage a rebound -- and if it does, its shares would be a steal at current levels. Can Inovio pull off a comeback?